Prevalence and Antimicrobial Resistance of Mycoplasma genitalium Infection Among Women Living With Human Immunodeficiency Virus in South Africa: A Prospective Cohort Study.
Ong, Jason J; Magooa, Mahlape Precious; Chikandiwa, Admire; Kelly, Helen; Didelot, Marie-Noelle; Muller, Etienne E; Maseko, Venessa; Segondy, Michel; Delany-Moretlwe, Sinead; Kularatne, Ranmini; +2 more...Mayaud, Philippe
; and HIV in Africa Research Partnership Study Group
(2019)
Prevalence and Antimicrobial Resistance of Mycoplasma genitalium Infection Among Women Living With Human Immunodeficiency Virus in South Africa: A Prospective Cohort Study.
Clinical Infectious Diseases, 69 (5).
pp. 873-876.
ISSN 1058-4838
DOI: 10.1093/cid/ciz045
; and HIV in Africa Research Partnership Study Group
(2019)
Prevalence and Antimicrobial Resistance of Mycoplasma genitalium Infection Among Women Living With Human Immunodeficiency Virus in South Africa: A Prospective Cohort Study.
Clinical Infectious Diseases, 69 (5).
pp. 873-876.
ISSN 1058-4838
DOI: 10.1093/cid/ciz045
This prospective cohort study of 622 women living with human immunodeficiency virus (HIV) from Johannesburg (2012) detected Mycoplasma genitalium in 7.4% (95% confidence interval [CI]: 5.5-9.7, 46/622), with detection more likely with lower CD4 counts(adjusted odds ratio [AOR] 1.02 per 10 cells/μL decrease, 95% CI: 1.00-1.03) and higher plasma HIV-1 RNA (AOR 1.15 per log copies/mL increase, 95% CI: 1.03-1.27). No mutations for macrolide/quinolone resistance was detected.
-
picture_as_pdf - Ong-Mayaud_Mycoplasma South Africa HARP_Clin Infect Dis_accepted version.pdf
-
subject - Accepted Version
-
- Available under Creative Commons: Attribution-NonCommercial-No Derivative Works 3.0
Downloads